Results 131 to 140 of about 42,003 (250)

“Atypical Glandular Cells” on Cervical Cytology: Correlation Between Glandular Cell Component Volume and Histological Follow‐Up

open access: yesDiagnostic Cytopathology, Volume 54, Issue 2, Page 71-77, February 2026.
ABSTRACT Background Atypical glandular cells (AGC) in cervical cytology, as defined by the Bethesda System, indicate nuclear atypia beyond reactive changes but without definitive features of malignancy. Although clinically significant because it prompts follow‐up procedures, no quantitative threshold exists for AGC diagnosis.
Havva Gokce Terzioglu   +2 more
wiley   +1 more source

A Case of Intraductal Papillary Mucinous Adenocarcinoma of the Pancreas with Rapid Progression to Rupture

open access: diamond, 2021
Yuma Suno   +5 more
openalex   +2 more sources

Cytological Features of Pancreatic Medullary Carcinoma Diagnosed by Endoscopic Ultrasound‐Guided Fine Needle Aspiration

open access: yesDiagnostic Cytopathology, Volume 54, Issue 2, Page E54-E58, February 2026.
ABSTRACT Pancreatic medullary carcinoma is an extremely rare tumor classified as a histological subtype of pancreatic ductal adenocarcinoma. We report a case of a pancreatic medullary carcinoma and describe its cytological features. A 75‐year‐old woman presented with lower back pain, epigastric discomfort, and a tumor‐like lesion in the pancreatic body.
Urara Okawa   +4 more
wiley   +1 more source

Minimally invasive surgical treatment of recurrent endometrial carcinoma: A systematic review

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 172, Issue 2, Page 866-878, February 2026.
Abstract Background While the role minimally invasive surgery (MIS) is established for primary endometrial carcinoma (EC), its feasibility in recurrent cases remains underexplored. Objective To systematically review the literature about MIS for EC recurrence.
Antonio Raffone   +12 more
wiley   +1 more source

Treatment and Outcomes for Patients With Inadequate Lymphadenectomy After Resection of Stage II Small Bowel Adenocarcinoma

open access: yesJournal of Surgical Oncology, Volume 133, Issue 2, Page 186-195, February 2026.
ABSTRACT Background and Objectives Adjuvant chemotherapy (AC) is considered for patients with stage II small bowel adenocarcinoma (SBA) with an inadequate lymphadenectomy; however, the prognostic role of additional high‐risk features (T4 primary, positive resection margin, poorly differentiated tumor, or lymphovascular invasion) is unknown.
Jackson A. Baril   +8 more
wiley   +1 more source

Inflammation and Cancer: Molecular Mechanisms and Therapeutic Targets

open access: yesMedComm, Volume 7, Issue 2, February 2026.
Chronic inflammation fuels tumorigenesis via “internal drivers” and “external attractions.” Targeting these core mechanisms with combined therapies/novel deliveries enables precise, potent anti‐inflammatory–antitumor treatment. ABSTRACT Inflammation is a core pathological factor regulating tumor initiation, progression, and therapeutic resistance, and ...
Xiaodie Liu   +4 more
wiley   +1 more source

Novel growth pattern‐specific digital marker of TILs improves stratification of lung adenocarcinoma patients

open access: yesThe Journal of Pathology, Volume 268, Issue 2, Page 164-175, February 2026.
Abstract Lung adenocarcinoma (LUAD) is one of the most prevalent forms of cancer and continues to be associated with high mortality rates, despite recent advances in cancer therapy. Effective risk stratification is critical for guiding treatment decisions and improving our understanding of disease mechanisms. However, current prognostic approaches face
Arwa AlRubaian   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy